Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery · Oakland, CA
NPI
1104956408
Since 2007
Specialty
Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery
Code 207VF0040X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
350 30th St, Suite 100
Oakland, CA, 94609
Phone (510) 204-1844
Groups this clinician bills Medicare through
Medicare paid, 2024
$365K
18,738 services
Medicare patients, 2024
585
Average age 75
Drug cost, 2024
$913K
2,467 prescriptions
Company payments, 2025
$482
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Frick was code J0585 (injection, onabotulinumtoxina, 1 unit), 16,600 times for 88 patients. In total Anna Frick billed 18,738 services in 59 codes, and Medicare paid $365K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 16,600 | 88 | $4.91 | $82K |
| 99214 Office E&M - Established | Office | 340 | 261 | $112.37 | $38K |
| 81003 Clinical Chemistry | Office | 299 | 201 | $2.20 | $658 |
| 99213 Office E&M - Established | Office | 199 | 166 | $79.35 | $16K |
| 99204 Office E&M - New | Office | 195 | 195 | $141.85 | $28K |
| 51701 Other Organ Systems | Office | 189 | 182 | $40.08 | $7,575 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 188 | 153 | $14.88 | $2,797 |
| 52287 Cystourethroscopy | Office | 133 | 89 | $342.98 | $46K |
| 52000 Cystourethroscopy | Office | 57 | 56 | $225.79 | $13K |
| 99215 Office E&M - Established | Office | 56 | 49 | $156.50 | $8,764 |
| 51728 Other Organ Systems | Office | 40 | 40 | $366.14 | $15K |
| 51797 Other Organ Systems | Office | 38 | 38 | $200.22 | $7,608 |
| 51741 Test - Miscellaneous | Office | 38 | 38 | $7.05 | $268 |
| 51784 Neurologic | Office | 38 | 38 | $31.55 | $1,199 |
| 57288 Other Organ Systems | Facility | 34 | 34 | $475.49 | $16K |
By year: 2022 $350K for 8,642 services; 2023 $411K for 13,307 services; 2024 $365K for 18,738 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 299 | 201 | $2.20 | $658 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Frick prescribed most often to Medicare patients was Estradiol, with 611 prescriptions and refills. In total Anna Frick wrote 2,467 Medicare prescriptions that cost $913K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 611 | 1,531 | 258 | $87K |
| Gemtesa Vibegron | 324 | 849 | 123 | $408K |
| Yuvafem Estradiol | 306 | 713 | 115 | $54K |
| Myrbetriq Mirabegron | 246 | 574 | 91 | $258K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 184 | 193 | 119 | $499 |
| Cephalexin Generic | 177 | 238 | 107 | $1,042 |
| Premarin Estrogens, Conjugated | 107 | 256 | 46 | $47K |
| Tamsulosin Hcl Generic | 82 | 174 | 30 | $1,171 |
| Tramadol Hcl Generic | 62 | 62 | 61 | $171 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 53 | 71 | 36 | $1,233 |
| Methenamine Hippurate Generic | 50 | 120 | 17 | $5,678 |
| Estring Estradiol | 47 | 140 | 18 | $25K |
| Fluconazole Generic | 21 | 21 | 15 | $146 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 19 | 19 | 18 | $118 |
| Imvexxy Estradiol | 18 | 50 | Under 11 | $11K |
Brand drugs: 775 claims; generic drugs: 1,692 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Frick $482 ($482 in general payments such as food, travel and fees) from 3 companies. The largest payer was Valencia Technologies Corporation with $338.
| Company | Payments | Amount |
|---|---|---|
| Valencia Technologies Corporation | 3 | $338 |
| Coloplast Corp | 1 | $125 |
| Abbvie Inc. ABBV | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.